Skip to main content

Koninklijke Philips NV

corporate_fare Company Profile

Koninklijke Philips NV

PHG·NYSE·Industrial Applications And Services·CIK 0000313216

Koninklijke Philips N.V. is a health technology company operating in North America, Greater China, and internationally. The company is structured into three main segments: Diagnosis & Treatment, Connected Care, and Personal Health. Within its Diagnosis & Treatment segment, Philips provides diagnostic imaging solutions, which include its ultrasound business unit, magnetic resonance imaging (MRI), computed tomography (CT), and diagnostic x-ray systems. This segment also encompasses Image Guided Therapy, offering both image guided therapy systems and image guided therapy devices. The Connected Care segment provides monitoring, enterprise informatics, and sleep and respiratory care solutions. Additionally, the Personal Health segment offers various personal health products. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. The company changed its name from Koninklijke Philips Electronics N.V. to Koninklijke Philips N.V. in May 2013.

Koninklijke Philips NV (NYSE:PHG) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for PHG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-28, rated 8/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for PHG spans 6-K, 20-F.

Recent high-impact activity:

  • Philips Q2 2026: 4% Sales Growth, Margin Boost from US Tariff Refund, Raised Full-Year Outlook
  • Philips Q2 Sales Rise 4%, Lifts Profit Outlook on $186M Tariff Refund
  • Philips Forms Landmark 7-Year Strategic Alliance with WellSpan Health for Imaging and AI Co-Development
  • Philips Finalizes 2025 Dividend with 2% Share Dilution
  • FDA Clears Philips' AI-Powered Elevate Plus Ultrasound, Boosting Diagnostic Efficiency

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
€17.83B EUR
Net Income
€897M EUR
Diluted EPS
€0.93 EUR
Gross Profit
€8.06B EUR
Operating Income
€1.42B EUR
Cash & Equivalents
€2.79B EUR
Total Debt
€8.03B EUR
Debt / Equity
0.73×
Net Margin
5.0%
Source: 20-F · filed 2026-02-19 · accession 0001628280-26-009470

Short Interest & Short Volume

3.35 days to cover

FINRA reported short interest of 2,597,201 shares in PHG as of the September 15, 2026 settlement, a 9.1% increase from the prior period — about 3.4 days to cover at its recent average daily volume. On October 2, 2026, 47.7% of PHG volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,597,201 shares as of September 15, 2026
Change vs prior period▲ 9.1%
Days to cover3.35 at avg daily volume of 774,936
Daily short volume (FINRA facilities)47.7% of 276,609 shares on October 2, 2026
5-day average short volume42.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

PHG files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with P →
$23.92
52-week range · as of 2026-07-28 $23.92 – $33.44
Market cap
$23.23B
Volume
836.3K (1.1× avg)
3-mo avg 772.7K
Live data · 2026-10-05 03:05 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PHG - Latest Insights

PHG
Jul 28, 2026, 6:11 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $23.84
Real-time Price: $23.92 info
Change: +$0.080 (+0.34%) info
Market Cap: $23.235B info
PHG
Jul 27, 2026, 2:52 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $25.29
Real-time Price: $23.92 info
Change: -$1.36 (-5%) info
Market Cap: $23.235B info
PHG
Jun 04, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $25.35
Real-time Price: $23.92 info
Change: -$1.43 (-6%) info
Market Cap: $23.235B info
PHG
Jun 02, 2026, 9:23 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $25.68
Real-time Price: $23.92 info
Change: -$1.76 (-7%) info
Market Cap: $23.235B info
PHG
Jun 02, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $25.68
Real-time Price: $23.92 info
Change: -$1.76 (-7%) info
Market Cap: $23.235B info
PHG
May 18, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $25.28
Real-time Price: $23.92 info
Change: -$1.36 (-5%) info
Market Cap: $23.235B info
PHG
May 06, 2026, 9:01 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $26.99
Real-time Price: $23.92 info
Change: Stock Split info
Market Cap: $23.235B info
PHG
May 06, 2026, 1:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $26.69
Real-time Price: $23.92 info
Change: Stock Split info
Market Cap: $23.235B info
PHG
Feb 19, 2026, 6:40 AM EST
Filing Type: 20-F
Importance Score:
9
Price at Filing: $31.31
Real-time Price: $23.92 info
Change: Stock Split info
Market Cap: $23.235B info
PHG
Feb 19, 2026, 6:37 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $31.31
Real-time Price: $23.92 info
Change: Stock Split info
Market Cap: $23.235B info
PHG
Feb 10, 2026, 7:58 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $31.91
Real-time Price: $23.92 info
Change: Stock Split info
Market Cap: $23.235B info
PHG
Feb 10, 2026, 7:34 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $31.91
Real-time Price: $23.92 info
Change: Stock Split info
Market Cap: $23.235B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets